Answers are grounded in this paper and cite their sources.
This study is aimed to compare the effectiveness of modern therapy including angiotensin receptor-neprilysin inhibitor (ARNI) and sodium-glucose cotransporter 2 inhibitors (SGLT2i) with conventional heart failure treatment in the real world.
No takes yet. Share an insight, caveat, or question.
Karlström et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: